The Efficacy of Fecal Microbiota Transplantation in Experimental Autoimmune Encephalomyelitis: Transcriptome and Gut

Sanwang Wang1, Hongliang Chen2, Xin Wen3

  • 1Department of Psychiatry, Binzhou Medical University Hospital, Binzhou, China.

Abstract

Insights

Fecal microbiota transplantation (FMT) reduced experimental autoimmune encephalomyelitis (EAE) severity in mice. FMT modulated gut microbiota and spinal cord gene expression, suggesting a microbiota-dependent protective mechanism against neuroinflammation.

Area of Science:

  • Neuroimmunology
  • Microbiome Research
  • Genomics

Background:

  • Experimental autoimmune encephalomyelitis (EAE) is a mouse model for multiple sclerosis.
  • Gut microbiota dysbiosis is implicated in autoimmune diseases.
  • Fecal microbiota transplantation (FMT) is a potential therapeutic strategy.

Purpose of the Study:

  • To investigate the protective effects of FMT on EAE in mice.
  • To elucidate the underlying gut microbiota-dependent mechanisms.
  • To analyze changes in the spinal cord transcriptome.

Main Methods:

  • EAE induction and FMT administration in mice.
  • Clinical EAE scoring and histological analysis (H&E staining).
  • 16S rRNA sequencing for gut microbiota profiling.
  • Transcriptome sequencing of mouse spinal cord tissue.
  • Correlation analysis between microbiota and gene expression.

Main Results:

  • FMT significantly reduced EAE clinical scores and spinal cord inflammation.
  • FMT altered gut microbiota composition, increasing Firmicutes and Proteobacteria, and decreasing Bacteroides and Actinobacteria.
  • FMT modulated spinal cord gene expression, particularly inflammatory and neuroprotective pathways, with Adlercreutzia abundance correlating with these changes.

Conclusions:

  • FMT demonstrates a protective effect against EAE in mice.
  • The therapeutic benefits of FMT are mediated by gut microbiota-dependent regulation of gene expression.
  • FMT may restore intestinal homeostasis and reduce neuroinflammation.